RxDoctor Payments Data

Taylor Bazemore

Clinical Cardiac Electrophysiology · Wilmington, NCNPI 1144648270

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (54.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 62.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $28,795 and has fallen 95.5% since, to $1,283 in 2025.

$62,457in general payments, 2019–2025

Across 331 payments — averaging $188.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$39K
  • Biotronik Inc.$16K
  • Boston Scientific$3K
  • Abbott$1K
  • Biosense Webster, Inc.$1K
  • Atricure, Inc.$782
  • plus $839 from 5 others

What the payments were for

  • Consulting fees$1,4382%
  • Grants$34,16055%
  • Travel & lodging$12,03019%
  • Food & beverage$13,70722%
  • Education$1,1222%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,457 in reported general payments places this provider in the 80th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.

See all clinical cardiac electrophysiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$393,743
Medicare patients
1,800
Services billed
4,728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban201$238,925
MultaqDronedarone Hcl18$24,589
XareltoRivaroxaban21$22,960
Metoprolol Succinate252$3,414
Amiodarone Hcl167$2,278
Diltiazem 24hr Er (Cd)Diltiazem Hcl39$1,305
Flecainide Acetate26$1,030
Losartan Potassium24$440
Colchicine16$409
Atorvastatin Calcium15$301
Amlodipine Besylate28$287
Diltiazem 24hr ErDiltiazem Hcl12$220
SotalolSotalol Hcl14$210
Pantoprazole Sodium26$164
Diltiazem Hcl15$160

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →